Published in Phytomedicine on January 01, 2010
Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci U S A (2012) 1.72
Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett (2011) 1.27
Tea and cancer prevention: epidemiological studies. Pharmacol Res (2011) 1.27
The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. J Mol Signal (2010) 1.26
α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis (2011) 1.16
Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res (2011) 1.12
Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected]. Life Sci (2010) 1.09
Polyphenols: key issues involved in chemoprevention of prostate cancer. Oxid Med Cell Longev (2012) 1.08
Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol Nutr Food Res (2011) 1.06
EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem (2011) 1.05
New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer. Nutr Cancer (2011) 0.98
Prostate cancer and the influence of dietary factors and supplements: a systematic review. Nutr Metab (Lond) (2014) 0.98
Green and black tea intake in relation to prostate cancer risk among Singapore Chinese. Cancer Causes Control (2012) 0.94
Rosemary (Rosmarinus officinalis) extract modulates CHOP/GADD153 to promote androgen receptor degradation and decreases xenograft tumor growth. PLoS One (2014) 0.94
Current nutraceuticals in the management of osteoarthritis: a review. Ther Adv Musculoskelet Dis (2012) 0.94
Associations of tea and coffee consumption with prostate cancer risk. Cancer Causes Control (2013) 0.94
Going Green: The Role of the Green Tea Component EGCG in Chemoprevention. J Carcinog Mutagen (2013) 0.93
Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem (2012) 0.92
Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer Lett (2012) 0.90
Anticancer activity of green tea polyphenols in prostate gland. Oxid Med Cell Longev (2012) 0.84
Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges. Semin Cancer Biol (2016) 0.83
Nigerian foodstuffs with prostate cancer chemopreventive polyphenols. Infect Agent Cancer (2011) 0.83
Novel targets for prostate cancer chemoprevention. Endocr Relat Cancer (2010) 0.80
Roles of autophagy induced by natural compounds in prostate cancer. Biomed Res Int (2015) 0.80
Quantification of total polyphenols, catechin, caffeine, L-theanine, determination of antioxidant activity and effect on antileishmanial drugs of ethiopian tea leaves extracts. Pharmacognosy Res (2015) 0.80
Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes Control (2013) 0.79
Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. J Clin Trials (2012) 0.78
Regulation of Id1 expression by epigallocatechin‑3‑gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells. Int J Oncol (2013) 0.78
Chronic over-nutrition and dysregulation of GSK3 in diseases. Nutr Metab (Lond) (2016) 0.77
Green Tea Extract Induces the Resistance of Caenorhabditis elegans against Oxidative Stress. Antioxidants (Basel) (2014) 0.77
The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression model. Cancer Prev Res (Phila) (2015) 0.77
(-)-Epigallocatechin-3-gallate Modulates the Differential Expression of Survivin Splice Variants and Protects Spermatogenesis During Testicular Torsion. Korean J Physiol Pharmacol (2013) 0.77
Bactericidal activity of green tea extracts: the importance of catechin containing nano particles. Sci Rep (2016) 0.75
Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review. Int Braz J Urol (2016) 0.75
Determination and estimation of pharmacokinetic profile of caffeine in form of extract of green tea leaves and its analogy with synthetic form. Indian J Pharm Sci (2011) 0.75
Effects of green tea extracts on the pharmacokinetics of quetiapine in rats. Evid Based Complement Alternat Med (2015) 0.75
Breast cancer chemopreventive and chemotherapeutic effects of Camellia Sinensis (green tea): an updated review. Electron Physician (2017) 0.75
Active Holistic Surveillance: The Nutritional Aspect of Delayed Intervention in Prostate Cancer. J Nutr Metab (2016) 0.75
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci Rep (2017) 0.75
Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges. Antioxidants (Basel) (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem (2000) 8.86
Apoptotic pathways: paper wraps stone blunts scissors. Cell (2000) 4.37
Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res (2006) 3.17
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res (2003) 2.80
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79
The chemistry of tea flavonoids. Crit Rev Food Sci Nutr (1997) 2.51
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst (1997) 2.39
Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol (2007) 2.38
A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res (1989) 2.18
Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev (1997) 2.16
Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl (2006) 2.13
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res (2005) 2.07
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev (2001) 1.87
Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res (2004) 1.84
Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer (2004) 1.80
Curcumin for chemoprevention of colon cancer. Cancer Lett (2007) 1.75
Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev (2007) 1.74
Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene (2003) 1.62
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene (2007) 1.57
Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proc Natl Acad Sci U S A (1990) 1.57
Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res (Phila) (2009) 1.56
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol (2000) 1.55
Chemoprevention of human prostate cancer by green tea catechins: two years later. A follow-up update. Eur Urol (2008) 1.51
Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett (1995) 1.48
Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem (2006) 1.47
Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control (2007) 1.45
A case-control study of diet and prostate cancer in Japan: possible protective effect of traditional Japanese diet. Cancer Sci (2004) 1.44
The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Cancer Res (1999) 1.42
A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer (2003) 1.41
Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol (2001) 1.33
Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control (1999) 1.32
Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol (2005) 1.31
Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate (2007) 1.29
The MCM complex: its role in DNA replication and implications for cancer therapy. Curr Cancer Drug Targets (2005) 1.29
A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control (2004) 1.28
Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007. Pathology (2007) 1.24
Cell signaling pathways altered by natural chemopreventive agents. Mutat Res (2004) 1.23
A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol (2005) 1.23
Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr (2004) 1.21
Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas. Carcinogenesis (2005) 1.19
Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr (2006) 1.18
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression. Carcinogenesis (2004) 1.18
Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci (2001) 1.16
Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food Chem Toxicol (2005) 1.14
Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochem Pharmacol (2002) 1.14
Direct inhibition of insulin-like growth factor-I receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell transformation. Cancer Epidemiol Biomarkers Prev (2007) 1.14
Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm Res (2008) 1.14
Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer (2000) 1.12
Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: genotoxicity. Food Chem Toxicol (2005) 1.12
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int J Cancer (2005) 1.09
Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr (2003) 1.08
No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer (2006) 1.08
Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm Res (2001) 1.06
Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev (2006) 1.05
Selective inhibition of steroid 5 alpha-reductase isozymes by tea epicatechin-3-gallate and epigallocatechin-3-gallate. Biochem Biophys Res Commun (1995) 1.05
Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene (2000) 1.04
Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int J Pharm (2004) 1.03
Tea and other beverage consumption and prostate cancer risk: a Canadian retrospective cohort study. Eur J Cancer Prev (2000) 1.03
Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem (2004) 1.03
Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chem Biol Interact (2007) 1.02
Oral absorption and bioavailability of tea catechins. Planta Med (2000) 1.00
Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats. Food Chem Toxicol (2006) 1.00
Epicatechins Purified from Green Tea (Camellia sinensis) Differentially Suppress Growth of Gender-Dependent Human Cancer Cell Lines. Evid Based Complement Alternat Med (2006) 0.99
Modulation of human glutathione s-transferases by polyphenon e intervention. Cancer Epidemiol Biomarkers Prev (2007) 0.98
Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer. Mol Oncol (2007) 0.97
Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos (2004) 0.92
Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model. Int J Cancer (2004) 0.89
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling. Carcinogenesis (2005) 0.88
Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab Dispos (2002) 0.85
Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer. Clin Transl Oncol (2007) 0.82
Formation of antioxidants from (-)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma. J Nutr Biochem (1999) 0.81
Differential expression of TRAIL and its receptors in benign and malignant prostate tissues. J Urol (2007) 0.81
Effect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea polyphenols in Caco-2 monolayer model. J Pharm Pharmacol (2006) 0.78
Increased resistance to trail-induced apoptosis in prostate cancer cells selected in the presence of bicalutamide. Prostate (2007) 0.78
Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79
Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem (1997) 2.57
Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst (1997) 2.39
Green tea and skin. Arch Dermatol (2000) 2.29
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate (2000) 2.19
Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72
Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys (2000) 1.63
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene (2007) 1.57
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol (2000) 1.55
Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl (1995) 1.52
Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr Rev (1999) 1.51
Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst (1997) 1.51
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis (2001) 1.48
Tea in chemoprevention of cancer. Int J Oncol (1996) 1.47
Genetic variation in low-dose UV-induced suppression of contact hypersensitivity and in the skin photocarcinogenesis response. J Invest Dermatol (1997) 1.47
Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res (2001) 1.43
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol (2001) 1.41
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancer. Cancer J Sci Am (1999) 1.39
Specific high-affinity binding of fatty acids to epidermal cytosolic proteins. J Invest Dermatol (1991) 1.38
Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol (2001) 1.35
Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol (2001) 1.34
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells. Oncogene (2008) 1.33
Photodynamic therapy in dermatology. J Am Acad Dermatol (2000) 1.28
Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun (2001) 1.27
Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem Photobiol (1999) 1.27
Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer (2001) 1.27
Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells. Oncogene (2006) 1.27
Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis (2009) 1.26
Ultraviolet-B exposure of human skin induces cytochromes P450 1A1 and 1B1. J Invest Dermatol (2000) 1.24
Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Cancer Res (2000) 1.24
Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res (1993) 1.22
Inhibition of tumor promotion in SENCAR mouse skin by ethanol extract of Zingiber officinale rhizome. Cancer Res (1996) 1.22
Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis (1999) 1.20
Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun (2000) 1.19
Cloning and sequencing of the cDNA for the light subunit of human liver gamma-glutamylcysteine synthetase and relative mRNA levels for heavy and light subunits in human normal tissues. Biochem Biophys Res Commun (1995) 1.19
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network. Ann Oncol (2006) 1.19
Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem Photobiol (1993) 1.17
Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res (2000) 1.16
Evolution of imaging for abdominal perforation. Ann R Coll Surg Engl (2010) 1.15
Antimutagenic activity of green tea polyphenols. Mutat Res (1989) 1.14
Tea antioxidants in cancer chemoprevention. J Cell Biochem Suppl (1997) 1.11
Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol (1999) 1.10
Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res (1992) 1.09
Induction of contact hypersensitivity to dimethylbenz(a)anthracene and benzo(a)pyrene in C3H/HeN mice. Cancer Res (1987) 1.07
Up-regulation of gamma-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levels. Cancer Chemother Pharmacol (1994) 1.07
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice. Clin Cancer Res (2000) 1.06
Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo: an immunohistochemical analysis of both epidermis and dermis. Photochem Photobiol (2000) 1.05
Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis (1991) 1.05
Transfection of complementary DNAs for the heavy and light subunits of human gamma-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan. Cancer Res (1995) 1.05
Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]-pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. J Invest Dermatol (1984) 1.05
Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol (1995) 1.04
Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res (1992) 1.03
Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives. Cancer Res (1992) 1.03
The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers. Photochem Photobiol (1997) 1.01
Tea consumption and cancer. World Rev Nutr Diet (1996) 1.01
Green tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNA. Clin Cancer Res (2000) 1.00
Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res (1999) 1.00
Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun (2000) 0.99
Differential role of reactive oxygen intermediates in photofrin-I- and photofrin-II-mediated photoenhancement of lipid peroxidation in epidermal microsomal membranes. J Invest Dermatol (1988) 0.99
Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol (1995) 0.99
In vitro and in vivo inhibition of epidermal growth factor receptor-tyrosine kinase pathway by photodynamic therapy. Oncogene (2001) 0.99
Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans. Clin Cancer Res (1999) 0.99
Involvement of Bcl-2 and Bax in photodynamic therapy-mediated apoptosis. Antisense Bcl-2 oligonucleotide sensitizes RIF 1 cells to photodynamic therapy apoptosis. J Biol Chem (2001) 0.98
Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis. Proc Natl Acad Sci U S A (1998) 0.98
Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res (1998) 0.97
Prostate cancer chemoprevention by green tea. Semin Urol Oncol (1999) 0.96
Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis (1993) 0.96
Inhibition of the skin tumorigenicity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice. Cancer Lett (1988) 0.94
Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin. Photochem Photobiol (1999) 0.93
A definitive role of ornithine decarboxylase in photocarcinogenesis. Am J Pathol (2001) 0.93
Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression. Photochem Photobiol (1997) 0.93
Effects of solar radiation on cutaneous detoxification pathways. J Photochem Photobiol B (2001) 0.93
A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Photochem Photobiol (1998) 0.93
Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res (1989) 0.93
A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of the xanthine oxidase pathway. J Clin Invest (1989) 0.93
Protection against benzo[a]pyrene- and N-nitrosodiethylamine-induced lung and forestomach tumorigenesis in A/J mice by water extracts of green tea and licorice. Carcinogenesis (1992) 0.92
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res (1992) 0.92
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. Clin Cancer Res (2000) 0.92
Novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. Biochem Biophys Res Commun (1996) 0.92
Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex. Proc Natl Acad Sci U S A (1998) 0.92
Glutathione S-transferases in human and rodent skin: multiple forms and species-specific expression. J Invest Dermatol (1991) 0.91
Protection against 12-O-tetradecanoylphorbol-13-acetate-caused inflammation in SENCAR mouse ear skin by polyphenolic fraction isolated from green tea. Carcinogenesis (1993) 0.90
Iron therapy for hepatic dysfunction in erythropoietic protoporphyria. Ann Intern Med (1986) 0.90
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study. Hematol Oncol (2009) 0.90
Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol (1998) 0.89
Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol (2000) 0.89
Photodynamic effects of new silicon phthalocyanines: in vitro studies utilizing rat hepatic microsomes and human erythrocyte ghosts as model membrane sources. Photochem Photobiol (1993) 0.89
Studies on microsomal cytochrome P-450, monooxygenases and epoxide hydrolase in cultured keratinocytes and intact epidermis from BALB/C mice. J Pharmacol Exp Ther (1982) 0.88
Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis (1989) 0.88
Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha. Biochem Biophys Res Commun (1997) 0.87
Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin. Photochem Photobiol (1996) 0.87
Activation of telomerase and its association with G1-phase of the cell cycle during UVB-induced skin tumorigenesis in SKH-1 hairless mouse. Oncogene (1999) 0.87
Protection against induction of mouse skin papillomas with low and high risk of conversion to malignancy by green tea polyphenols. Carcinogenesis (1997) 0.87
Induction of neonatal rat skin and liver aryl hydrocarbon hydroxylase by coal tar and its constituents. J Invest Dermatol (1982) 0.85
Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice. Carcinogenesis (1994) 0.85
Effects of phenobarbital and 3-methylcholanthrene administration on glutathione-S-epoxide transferase activity in rat liver. Biochem Pharmacol (1976) 0.85
Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53. Biochem Biophys Res Commun (2000) 0.85
Effect of phenobarbital and 3-methylcholanthrene administration on epoxide hydrase levels in liver microsomes. Biochem Pharmacol (1977) 0.85
Involvement of singlet oxygen in chloroaluminum phthalocyanine tetrasulfonate-mediated photoenhancement of lipid peroxidation in rat epidermal microsomes. Cancer Lett (1991) 0.85
In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization. Biochem Biophys Res Commun (1988) 0.85